CTRI/2025/07/091464
Not yet recruiting
Phase 2/3
A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF VISHATAILA LEPA IN DADRU KUSTHA W.S.R TO TINEA CORPORIS
SDM AYURVEDA COLLEGE HOSPITAL AND RESEARCH CENTRE1 site in 1 country30 target enrollmentStarted: July 23, 2025Last updated:
Overview
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- SDM AYURVEDA COLLEGE HOSPITAL AND RESEARCH CENTRE
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- A Number of Mandala
Overview
Brief Summary
THIS IS A OPEN LABLE RANDOMISED CONTROLLED INTERVENTIONAL STUDY THAT WILL CHECK THE EFFICTIVENESS OF VISHATAILA LEPA IN TREATING DADRU KUSTHA ALSO COMPARE IT TO STANDARD DURVADITAILA LEPA AND CHECK IT ON 14 AND 28 DAYS WITH PRIMARY OUTCOMES AS DECREASE IN No. of Mandala (Circular lesions) , Size of Mandala, Raaga , No. of Pidaka (lesion), WHERE AS SECONDARY OUTCOMES AS DECREASE IN Kandu , Daha, Rookshata.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 70.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •patient full filling the following criteria of Dadru kustha presence of Udgata mandala with or without other features 1 Central Clearing and peripheral spreading 2 Kandu 3 Raaga 4 Pidaka 5 Daha 6 Rookshata 7 Udgata mandala 8 KOH positive skin scrapings obtained from most seriously affected lesion.
Exclusion Criteria
- •1 Subjects having any uncontrolled systemic illness which can interfere with the course of disease and treatment 2 Other overlapping dermatological diseases will be excluded 3 Subjects under Anti-Fungal drugs will be excluded.
Outcomes
Primary Outcomes
A Number of Mandala
Time Frame: AT 0,14,28 DAY
B Size of Mandala
Time Frame: AT 0,14,28 DAY
C Raaga
Time Frame: AT 0,14,28 DAY
D Number of Pidaka
Time Frame: AT 0,14,28 DAY
Secondary Outcomes
- A Kandu(B Daha)
Investigators
DR SANDEEP
SDM AYURVEDA COLLEGE, HOSPITAL AND RESEARCH CENTRE
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Phase 3
Clinical trial to evaluate effect of local application of Sharapunkha Malahar in the management of infected woundCTRI/2024/10/074600Dr Raut Rohit Ashok30
Completed
Not Applicable
A Study to Check the Safety and Effectiveness of Dharasana Lep in People with Mild to Moderate Muscle, Joint, or Rheumatic PainCTRI/2025/07/091299Shah Maganlal Chunilal Gandhi35
Not yet recruiting
Phase 2
A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICCNCT07432568Tianjin Medical University Cancer Institute and Hospital30
Not yet recruiting
Phase 3
A study to see how a homoeopathic medicine bacillus morgan pure works in treating dermatitisCTRI/2025/09/095072Dr MPK Homoeopathy Medical College Hospital and Research Centre60
Recruiting
Not Applicable
Transcranial Alternating Current Stimulation in Lewy Body DementiaNCT07375771IRCCS Centro San Giovanni di Dio Fatebenefratelli40